Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles

被引：5
|
作者：
Dellacasa, Chiara Maria [1 ]
Busca, Alessandro [1 ]
Audisio, Ernesta [2 ]
Marmont, Filippo [2 ]
Barbui, Anna Maria [3 ]
Falda, Michele [1 ]
De Rosa, Francesco Giuseppe [4 ]
Frairia, Chiara [2 ]
Allione, Bernardino [2 ]
D'Ardia, Stefano [2 ]
Aydin, Semra [2 ]
Pecoraro, Clara [2 ]
Manetta, Sara [1 ]
Vitolo, Umberto [2 ]
机构：
[1] AO Citta Salute & Sci, SSCVD Trapianto Cellule Staminali Allogen, Turin, Italy
[2] AO Citta Salute & Sci, SC Ematol, Turin, Italy
[3] AO Citta Salute & Sci, SC Microbiol, Turin, Italy
[4] AO Amedeo Savoia, Dipartimento Sci Med, Turin, Italy
来源：
JOURNAL OF CHEMOTHERAPY | 2014年 / 26卷 / 05期
关键词：
CELL TRANSPLANT RECIPIENTS; ACUTE MYELOGENOUS LEUKEMIA; ANTIFUNGAL PROPHYLAXIS; HEMATOLOGIC MALIGNANCIES; CLINICAL EFFECTIVENESS; NEUTROPENIC PATIENTS; FLUCONAZOLE; ASPERGILLOSIS; ITRACONAZOLE; EPIDEMIOLOGY;
D O I：
10.1179/1973947813Y.0000000142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：315 / 320
页数：6
相关论文
共 14 条
  • [1] Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis
    De Kort, Elizabeth A.
    Buil, Jochem B.
    Schalekamp, Steven
    Schaefer-Prokop, Cornelia
    Verweij, Paul E.
    Schaap, Nicolaas P. M.
    Blijlevens, Nicole M. A.
    Van der Velden, Walter J. F. M.
    JOURNAL OF FUNGI, 2022, 8 (09)
  • [2] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    Dranitsaris, George
    Khoury, Haytham
    SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1807 - 1813
  • [3] Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009)
    Klingspor, Lena
    Saaedi, Baharak
    Ljungman, Per
    Szakos, Attila
    MYCOSES, 2015, 58 (08) : 470 - 477
  • [4] Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients A retrospective observational study
    Chen, Xiaochen
    Wang, Jianxiang
    Wang, Sanbin
    Jin, Jie
    Li, Junmin
    Gao, Sujun
    Li, Jianyong
    Li, Juan
    Liu, Qifa
    Hu, Yu
    Lin, Dongjun
    Sun, Zimin
    Yang, Jianmin
    Hu, Jianda
    Wu, Xiaoxiong
    Huang, Xiaojun
    Shao, Zonghong
    Deng, Qi
    Wang, Chun
    Liu, Li
    Chen, Hu
    Wang, Jingbo
    Wei, Xudong
    Shen, Jianping
    Zhang, Xi
    Wu, Depei
    MEDICINE, 2021, 100 (30) : E26772
  • [5] Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
    Dahlen, Torsten
    Kalin, Mats
    Cederlund, Kerstin
    Nordlander, Anna
    Bjorkholm, Magnus
    Ljungman, Per
    Blennow, Ola
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (02) : 175 - 180
  • [6] Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
    Tormo, Mar
    Perez-Martinez, Ariadna
    Calabuig, Marisa
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    Solano, Carlos
    MYCOSES, 2018, 61 (03) : 206 - 212
  • [7] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    George Dranitsaris
    Haytham Khoury
    Supportive Care in Cancer, 2011, 19 : 1807 - 1813
  • [8] Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study
    Wu, Han
    Li, Manning
    Shou, Chunyi
    Shi, Fangfang
    Song, Xiaolu
    Hu, Qingfeng
    Wang, Ying
    Chen, Yirui
    Tong, Xiangmin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [9] Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations
    Cho, Sung-Yeon
    Lee, Dong-Gun
    Choi, Su-Mi
    Choi, Jae-Ki
    Lee, Hyo-Jin
    Kim, Si-Hyun
    Park, Sun Hee
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Min, Woo-Sung
    MYCOSES, 2015, 58 (09) : 565 - 571
  • [10] Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis A single-center, observational, case-control study in South Korea
    Yang, Eunmi
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Kim, Sung-Han
    MEDICINE, 2021, 100 (20) : E25448
12